Peptide distributors and suppliers occupy a critical—and risky—position in the supply chain. Errors & Omissions insurance protects you when your professional guidance, documentation, or representations lead to a downstream claim.
PRIA Brokers
PRIA Brokers — Peptide Insurance Specialist
Peptide distributors occupy a unique position: they don't manufacture the product, and they often don't sell directly to end users. Yet when something goes wrong in the supply chain, distributors frequently find themselves named in litigation alongside manufacturers and end-users.
The legal theory is simple: as a commercial intermediary, you are expected to know your product, verify your suppliers, and accurately represent the quality and characteristics of what you're selling. When that representation turns out to be wrong—through no fault of your own—you may still face significant liability.
General liability insurance covers bodily injury and property damage caused by a product. But many claims against peptide distributors don't arise from physical harm—they arise from:
**Incorrect documentation** (CoA errors, mislabeled potency)
**Supplier misrepresentation** that you unknowingly passed along
**Regulatory misinformation** about what's legal to sell in a given jurisdiction
**Technical consulting** provided to customers about formulation or dosing
**Failure to warn** about known supply chain issues
These are professional liability claims—and they require Errors & Omissions (E&O) coverage to respond properly.
An E&O policy designed for peptide distributors covers claims arising from:
If you provide a Certificate of Analysis (CoA) that contains errors—whether yours or your supplier's—and a customer relies on that CoA to make a procurement decision, the resulting claim falls squarely in E&O territory.
Many distributors provide guidance to customers on peptide selection, storage, handling, and formulation compatibility. If that advice is wrong, and a customer suffers a loss as a result, professional liability coverage responds.
Distributors are frequently asked whether a particular compound is legal to sell for a particular use. If you provide incorrect guidance about FDA status, DEA scheduling, or import/export regulations, E&O coverage protects against the resulting claim.
If a supplier provides false or misleading information about a peptide's origin, purity, or manufacturing process, and you pass that information to your customers, you may be liable even though you were also deceived. E&O coverage addresses your liability in this scenario.
A peptide distributor received a third-party CoA from their overseas supplier showing 99.2% purity for a batch of BPC-157. They forwarded the CoA to their downstream compounding pharmacy customer.
The pharmacy formulated the peptide and dispensed it to patients. Several adverse events occurred. An investigation revealed the batch was actually 91% pure, with unexpected impurities. The supplier had provided a fraudulent CoA.
The distributor was named in lawsuits by the pharmacy and by individual patients. Their defense: they relied on the supplier's CoA in good faith and had no way to know it was false.
The litigation cost the distributor $340,000 in legal fees and resulted in a settlement. Without E&O coverage, this was a near-existential financial event.
With a properly structured E&O policy, these costs would have been largely covered.
For most peptide distributors, the ideal program combines:
**Products liability coverage** – for bodily injury or property damage caused by a distributed product
**Errors & Omissions coverage** – for professional liability claims arising from documentation, advice, or representations
**Regulatory defense** – for FDA or FTC inquiries that may arise from distribution activities
PRIA Brokers structures these programs as a cohesive package, ensuring there are no coverage gaps between the policies and that the limits work together effectively.
If you're a peptide distributor with existing commercial insurance, ask your broker the following:
1. Does my general liability policy exclude pharmaceutical or peptide products?
2. Do I have professional liability (E&O) coverage, and does it specifically cover technical advice and documentation errors?
3. What are my limits, and are they adequate for the size of my transactions?
4. Is there regulatory defense coverage if the FDA or FTC investigates my distribution practices?
If you don't know the answers—or if the answers concern you—contact PRIA Brokers at (888) 998-7742 or info@priabrokers.com for a policy review and competitive quote.
PRIA Brokers specializes in coverage for peptide manufacturers, GLP-1 compounders, distributors, and suppliers. Compare quotes from A-rated specialty carriers.